These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 33997800)

  • 1. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.
    Drake TM; Fairfield CJ; Pius R; Knight SR; Norman L; Girvan M; Hardwick HE; Docherty AB; Thwaites RS; Openshaw PJM; Baillie JK; Harrison EM; Semple MG;
    Lancet Rheumatol; 2021 Jul; 3(7):e498-e506. PubMed ID: 33997800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.
    Bloom CI; Drake TM; Docherty AB; Lipworth BJ; Johnston SL; Nguyen-Van-Tam JS; Carson G; Dunning J; Harrison EM; Baillie JK; Semple MG; Cullinan P; Openshaw PJM;
    Lancet Respir Med; 2021 Jul; 9(7):699-711. PubMed ID: 33676593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
    PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study.
    Reese JT; Coleman B; Chan L; Blau H; Callahan TJ; Cappelletti L; Fontana T; Bradwell KR; Harris NL; Casiraghi E; Valentini G; Karlebach G; Deer R; McMurry JA; Haendel MA; Chute CG; Pfaff E; Moffitt R; Spratt H; Singh JA; Mungall CJ; Williams AE; Robinson PN
    Virol J; 2022 May; 19(1):84. PubMed ID: 35570298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort study.
    Reese JT; Coleman B; Chan L; Blau H; Callahan TJ; Cappelletti L; Fontana T; Bradwell KR; Harris NL; Casiraghi E; Valentini G; Karlebach G; Deer R; McMurry JA; Haendel MA; Chute CG; Pfaff E; Moffitt R; Spratt H; Singh J; Mungall CJ; Williams AE; Robinson PN
    medRxiv; 2021 Dec; ():. PubMed ID: 33907758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
    Docherty AB; Mulholland RH; Lone NI; Cheyne CP; De Angelis D; Diaz-Ordaz K; Donegan C; Drake TM; Dunning J; Funk S; García-Fiñana M; Girvan M; Hardwick HE; Harrison J; Ho A; Hughes DM; Keogh RH; Kirwan PD; Leeming G; Nguyen Van-Tam JS; Pius R; Russell CD; Spencer RG; Tom BD; Turtle L; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
    Lancet Respir Med; 2021 Jul; 9(7):773-785. PubMed ID: 34000238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Drake TM; Riad AM; Fairfield CJ; Egan C; Knight SR; Pius R; Hardwick HE; Norman L; Shaw CA; McLean KA; Thompson AAR; Ho A; Swann OV; Sullivan M; Soares F; Holden KA; Merson L; Plotkin D; Sigfrid L; de Silva TI; Girvan M; Jackson C; Russell CD; Dunning J; Solomon T; Carson G; Olliaro P; Nguyen-Van-Tam JS; Turtle L; Docherty AB; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
    Lancet; 2021 Jul; 398(10296):223-237. PubMed ID: 34274064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
    Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
    Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza.
    Lund LC; Reilev M; Hallas J; Kristensen KB; Thomsen RW; Christiansen CF; Sørensen HT; Johansen NB; Brun NC; Voldstedlund M; Støvring H; Thomsen MK; Christensen S; Pottegård A
    JAMA Netw Open; 2020 Jul; 3(7):e2013880. PubMed ID: 32609352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19.
    Bruce E; Barlow-Pay F; Short R; Vilches-Moraga A; Price A; McGovern A; Braude P; Stechman MJ; Moug S; McCarthy K; Hewitt J; Carter B; Myint PK
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32785086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis.
    Zhou Q; Zhao S; Gan L; Wang Z; Peng S; Li Q; Liu H; Liu X; Wang Z; Shi Q; Estill J; Luo Z; Wang X; Liu E; Chen Y
    EClinicalMedicine; 2022 Apr; 46():101373. PubMed ID: 35434582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious Clinical Outcomes of COVID-19 Related to Acetaminophen or NSAIDs from a Nationwide Population-Based Cohort Study.
    Kim JW; Yoon S; Lee J; Lee S
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative Nonsteroidal Anti-inflammatory Drugs (NSAID) Administration and Acute Kidney Injury (AKI) in Major Gastrointestinal Surgery: A Prospective, Multicenter, Propensity Matched Cohort Study.
    STARSurg Collaborative
    Ann Surg; 2022 May; 275(5):904-910. PubMed ID: 33074883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study.
    Reyes LF; Murthy S; Garcia-Gallo E; Merson L; Ibáñez-Prada ED; Rello J; Fuentes YV; Martin-Loeches I; Bozza F; Duque S; Taccone FS; Fowler RA; Kartsonaki C; Gonçalves BP; Citarella BW; Aryal D; Burhan E; Cummings MJ; Delmas C; Diaz R; Figueiredo-Mello C; Hashmi M; Panda PK; Jiménez MP; Rincon DFB; Thomson D; Nichol A; Marshall JC; Olliaro PL;
    Crit Care; 2022 Sep; 26(1):276. PubMed ID: 36100904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    Wainstein M; MacDonald S; Fryer D; Young K; Balan V; Begum H; Burrell A; Citarella BW; Cobb JP; Kelly S; Kennon K; Lee J; Merson L; Murthy S; Nichol A; Semple MG; Strudwick S; Webb SA; Rossignol P; Claure-Del Granado R; Shrapnel S;
    PLoS Med; 2022 Apr; 19(4):e1003969. PubMed ID: 35442972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
    Vergis N; Phillips R; Cornelius V; Katsarou A; Youngstein T; Cook L; Willicombe M; Pilay C; Shturova T; Almonte M; Charania A; Turner R; Kon OM; Cooke G; Thursz M; Cherlin S; Wason J; Milojkovic D; Innes AJ; Cooper N
    Trials; 2021 Apr; 22(1):270. PubMed ID: 33845867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do early non-steroidal anti-inflammatory drugs for analgesia worsen acute kidney injury in critically ill trauma patients? An inverse probability of treatment weighted analysis.
    Hatton GE; Bell C; Wei S; Wade CE; Kao LS; Harvin JA
    J Trauma Acute Care Surg; 2020 Oct; 89(4):673-678. PubMed ID: 32649618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.